Biomedical engineering is at a pivotal moment. After 2025 the field is ready to deliver therapies and devices that were unthinkable a decade ago. The convergence of artificial‑intelligence‑driven computing, gene and cell therapies, bioelectronics, wearables, robotics, and in‑silico modelling promises to reshape clinical practice. Yet these advances also raise questions about ethics, regulation and workforce readiness. The global BME market, valued at approximately $227 billion in 2022, is projected to grow at a CAGR of

Introduction The issue of hearing impairment is a significant public health hazard in Pakistan, affecting roughly 4.8 percent or around 10 million people [1]. This number is revealed by a Rapid Assistive Technology survey conducted by the Ministry of National Health Services, Regulations, and Coordination. This problem becomes more pertinent with children, where any delays in diagnosis could result in severe developmental challenges like impairment in speech, language, and educational outcomes[2]. Systemic, economic, and culture-laden